|Mr. Terukazu Kato||Pres, CEO & Representative Director||126M||N/A||1963|
|Mr. Muneki Handa||CFO & Director||N/A||N/A||1962|
|Mr. Koin Toda||Co-Chief Operating Officer||N/A||N/A||N/A|
|Mr. Kei Sugii||Co-COO & Director||N/A||N/A||1969|
|Hiroshi Hoshi||GM of Legal & Compliance Control and Exec. Officer||N/A||N/A||N/A|
|Yukinori Sorata||Exec Officer, GM of Prescription Pharmaceutical Sales Div and Head of Sales & Marketing Division||N/A||N/A||N/A|
|Mr. Susumu Adachi||Chief HR Officer||N/A||N/A||1963|
|Mr. Kimitoshi Usui||Head of Production Division||N/A||N/A||N/A|
|Mr. Ryouichi Murata||Mang. of Tsumura Academy & Exec. Officer||N/A||N/A||N/A|
|Tadahiro Abe||GM of Healthcare Division & Exec. Officer||N/A||N/A||N/A|
Tsumura & Co. manufactures and sells pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines; and sale of pharmaceuticals and food products. The company was founded in 1893 and is headquartered in Tokyo, Japan.
Tsumura & Co.’s ISS Governance QualityScore as of September 28, 2023 is 2. The pillar scores are Audit: 1; Board: 2; Shareholder Rights: 7; Compensation: 2.